# What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

> **NCT04436978** · PHASE4 · RECRUITING · sponsor: **St. Antonius Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Myocardial Infarction
- Atrial Fibrillation
- Atrial Flutter
- STEMI - ST Elevation Myocardial Infarction
- NSTEMI - Non-ST Segment Elevation MI
- Bleeding
- Stroke
- Stent Thrombosis
- Embolism
- Coronary Artery Disease

## Interventions

- **DRUG:** 30-day DAPT
- **DRUG:** Guideline-directed therapy

## Key facts

- **NCT ID:** NCT04436978
- **Lead sponsor:** St. Antonius Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-11
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2023-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04436978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04436978, "What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04436978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*